Ma'An Muhsin

Ma'an Muhsin, M.D. is an experienced professional in the field of oncology and immuno-oncology, currently serving as the Head of Clinical, Safety & Pharmacovigilance at Arrowhead Pharmaceuticals and as the Chief Medical Officer and President of the Kriya Oncology Division at Kriya Therapeutics. Ma'an has held various leadership positions in multiple organizations, including serving as a Medical Consultant at JANUS MM BioConsulting and previously as Chief Medical Officer at Medicenna Therapeutics Corp. and Nektar Therapeutics. With a strong focus on clinical development strategy, medical monitoring, and trial design, Ma'an has contributed to notable advancements in cancer immunotherapy, including the introduction of Kriya's "Immunogene Therapy." Ma'an's extensive experience is further complemented by a medical degree from a reputable School of Medicine.